Zinc PCA Powder (≥98% purity) is a high‑performance, sebum‑regulating active ingredient supplied by Polygon Life Science, a premier B2B supplier of specialty cosmetic raw materials. As a trusted cosmetic ingredient supplier, we manufacture this zinc PCA for formulators developing acne control products, mattifying moisturizers, and sebum‑regulating serums that require both oil control and hydration – without the drying side effects typical of zinc salts.
Unlike conventional zinc gluconate or zinc sulfate, our zinc PCA powder combines the antimicrobial and anti‑inflammatory power of zinc with the Natural Moisturizing Factor (NMF) intelligence of PCA. This non‑drying acne treatment ingredient maintains skin moisture while reducing sebum excretion rate by approximately 30% (in vitro). It is the preferred sebum regulating ingredient for oily skin formulations, blemish spot treatments, and men's grooming lotions.
Dual‑action zinc and PCA complex.
Sebum regulation, anti‑inflammatory, and non‑drying hydration.
White to off‑white fluffy fine powder
≥98% purity (HPLC) with zinc content 8–9%
Moisture-protected packaging
Made with no allergen-containing ingredients
Bulk Amounts Available Now
Consistent performance across formulations
Blemish spot treatments & acne control serums
Mattifying moisturizers for oily and combination skin
Sebum‑regulating scalp products
Stable between pH 5.0 and 6.5. Above pH 7.0, zinc hydroxide may precipitate as a white haze. Below pH 4.5, the PCA moiety protonates, reducing hydration efficacy. We recommend a citrate or lactate buffer if your formula drifts outside this range. We provide pH stability data for 12 months.
No – Zn‑PCA requires water to release zinc ions and hydrate the PCA moiety. For anhydrous systems, consider encapsulated zinc or suspend Zn‑PCA in a polar oil with trace water (e.g., caprylic/capric triglyceride + 0.5% water). Best performance is achieved in water‑continuous phases (o/w emulsions, hydrogels).
Yes – in‑vitro study on human sebocyte cultures shows 29.7% reduction in lipid droplet area after 48 hours at 0.5% active. An ongoing in‑vivo study (20 subjects, 4 weeks, 2% Zn‑PCA in gel) preliminary data shows 26% reduction in sebumetry readings. Full reports available under NDA.